Skip to main content
. Author manuscript; available in PMC: 2023 Jan 1.
Published in final edited form as: Clin Pharmacol Ther. 2021 Sep 1;111(1):145–149. doi: 10.1002/cpt.2398

Table 1.

Breaking down the PICOT question can highlight mismatches between the question of interest and question being asked

Your clinical or policy question RWE study question
Population   Patients 65+ with type 2 diabetes Patients 40–65 with diagnosis of type 2 diabetes measured in the 180 days prior to and including the date of treatment initiation
Intervention   Drug X Drug X
Comparator   Drug Y Drug Z
Outcome   Hospitalization for heart failure Hospitalization with heart failure diagnosis as primary discharge diagnosis
Timing   On-treatment follow-up
  Starts: Day after treatment initiation
  Stops: End of treatment, switching therapies, death or disenrollment
Intention-to-treat follow-up
Starts: Day after treatment initiation
Stops: Death, disenrollment, 730 days after initiation

PICOT, Population, Intervention, Comparator, Outcome, and Timing; RWE, real-world evidence.